Treatment Action Group (TAG) released the 2018 Pipeline Report – TAG’s annual review of therapeutics, diagnostics, vaccines, and preventive technologies in development for HIV, HCV, and TB, along with immune-based and gene therapies and research toward a cure for HIV.
The report has a new format this year – a comprehensive bound version will not be published. The released pages are intended to serve as living documents, to be updated regularly by TAG staff with news of registrational approvals, research and development discontinuations, new entries, and pertinent clinical trial data. Additional pages will be added later this summer and fall.
The report can be accessed here.